Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7670)
All Articles published online
|
Publishing Process of This Article
|
Feb 6, 2016 (publication date) through Aug 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Picardi A, Vespasiani-Gentilucci U. Proton pump inhibitor prescription abuse and sepsis in cirrhosis. World J Gastrointest Pharmacol Ther 2016; 7(1): 1-4 [PMID: 26855807 DOI: 10.4292/wjgpt.v7.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v7/i1/1.htm |
| Number | Citing Articles |
| 1 |
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 2017; 37(7): 587 doi: 10.1007/s40261-017-0519-y
|
| 2 |
Angela Horvath, Florian Rainer, Mina Bashir, Bettina Leber, Bianca Schmerboeck, Ingeborg Klymiuk, Andrea Groselj-Strele, Marija Durdevic, Daniel E. Freedberg, Julian A. Abrams, Peter Fickert, Philipp Stiegler, Vanessa Stadlbauer. Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48352-5
|
| 3 |
Jiamin Gao, Senlin Ma, Siyuan Xu, Mingquan Chen, Ihtisham Bukhari. The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/4093595
|
| 4 |
Wisam Sbeit, Hani Abukaes, Helal Said Ahmad, Moeen Sbeit, Itai Kalisky, Lior Katz, Amir Mari, Tawfik Khoury. The possible association of proton pump inhibitor use with acute cholangitis in patients with choledocholithiasis: a multi-center study. Scandinavian Journal of Gastroenterology 2023; 58(1): 83 doi: 10.1080/00365521.2022.2106150
|
| 5 |
D. K. Li, P. Yan, A‐B. Abou‐Samra, R. T. Chung, A. A. Butt. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES. Alimentary Pharmacology & Therapeutics 2018; 47(2): 246 doi: 10.1111/apt.14391
|
| 6 |
Petra Witt, Esther W. Siegers, Mauricio Tobón Restrepo, Robin van den Boom. Successful treatment of a hepatic abscess in a pony by percutaneous drainage and antimicrobial therapy. Veterinary Record Case Reports 2021; 9(4) doi: 10.1002/vrc2.164
|
| 7 |
Hasan Jaber, Sandra Chehayeb, Janane Nasr, Nader Al Souky, Daly Al Hadeethi, Hyrettin Okut, Mathew Stotts, William J. Salyers. Proton Pump Inhibitor Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-Analysis. Clinics and Research in Hepatology and Gastroenterology 2025; : 102667 doi: 10.1016/j.clinre.2025.102667
|